These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11747791)

  • 21. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
    Espinal P; Roca I; Vila J
    Future Microbiol; 2011 May; 6(5):495-511. PubMed ID: 21585259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carriage of OXA-58 but not of OXA-51 beta-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii.
    Tsakris A; Ikonomidis A; Pournaras S; Spanakis N; Markogiannakis A
    J Antimicrob Chemother; 2006 Nov; 58(5):1097-9. PubMed ID: 16997843
    [No Abstract]   [Full Text] [Related]  

  • 23. IMP-1 carbapenemase detected in an Acinetobacter clinical isolate from the UK.
    Tysall L; Stockdale MW; Chadwick PR; Palepou MF; Towner KJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2002 Jan; 49(1):217-8. PubMed ID: 11751794
    [No Abstract]   [Full Text] [Related]  

  • 24. Multilocus sequence typing and molecular characterization of β-lactamase genes among Acinetobacter baumannii isolates in a burn center.
    Huang G; Peng Y; Yang Y; Tang C; Fu Y
    Burns; 2017 Nov; 43(7):1473-1478. PubMed ID: 28461077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates.
    Kim DH; Choi JY; Jung SI; Thamlikitkul V; Song JH; Ko KS
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4548-9. PubMed ID: 22687501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
    Loli A; Tzouvelekis LS; Gianneli D; Tzelepi E; Miriagou V
    Antimicrob Agents Chemother; 2008 May; 52(5):1894-6. PubMed ID: 18285473
    [No Abstract]   [Full Text] [Related]  

  • 27. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain.
    Merino M; Poza M; Roca I; Barba MJ; Sousa MD; Vila J; Bou G
    Microb Drug Resist; 2014 Aug; 20(4):259-63. PubMed ID: 24328852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High endemic rates of OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates caused by the persistence of major clones in hospitals in a Brazilian city 5 years after an outbreak.
    Pagano M; Barin J; Martins AF; Zavascki AP
    Infect Control Hosp Epidemiol; 2015 Jul; 36(7):860-2. PubMed ID: 25773462
    [No Abstract]   [Full Text] [Related]  

  • 29. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
    Tamma PD; Wang R; Lewis S; Opene BNA; Simner PJ
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1378-1379. PubMed ID: 28965496
    [No Abstract]   [Full Text] [Related]  

  • 31. Fortuitous diagnosis of NDM-1-producing Acinetobacter pittii carriage in a patient from France with no recent history of travel.
    Pailhoriès H; Hadjadj L; Mahieu R; Crochette N; Rolain JM; Kempf M
    J Antimicrob Chemother; 2017 Mar; 72(3):942-944. PubMed ID: 27999060
    [No Abstract]   [Full Text] [Related]  

  • 32. Carbapenemases among Acinetobacter species isolated from NICU of a tertairy care hospital in Karachi.
    Indhar F; Durrani MA; Bux A; Sohail M
    J Pak Med Assoc; 2017 Oct; 67(10):1547-1551. PubMed ID: 28955072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ISAba1/bla
    Meshkat Z; Amini Y; Sadeghian H; Salimizand H
    Infect Genet Evol; 2019 Jul; 71():60-66. PubMed ID: 30902743
    [No Abstract]   [Full Text] [Related]  

  • 34. Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina.
    Afzal-Shah M; Villar HE; Livermore DM
    J Antimicrob Chemother; 1999 Jan; 43(1):127-31. PubMed ID: 10381110
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
    Agoba EE; Govinden U; Peer AKC; Osei Sekyere J; Essack SY
    Microb Drug Resist; 2018 Nov; 24(9):1289-1295. PubMed ID: 29653481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.
    Mitchell JM; Leonard DA
    Antimicrob Agents Chemother; 2014 Nov; 58(11):7015-6. PubMed ID: 25155607
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
    Huang L; Sun L; Xu G; Xia T
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.